These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
62 related articles for article (PubMed ID: 2123065)
1. Impact of advanced age on the management of acute nonlymphocytic leukemia: a study of 103 patients. Orlandi E; Lazzarino M; Morra E; Castagnola C; Alessandrino EP; Bernasconi P; Bonfichi M; Bernasconi C Acta Haematol; 1990; 84(3):144-8. PubMed ID: 2123065 [TBL] [Abstract][Full Text] [Related]
2. Acute nonlymphocytic leukemia in the elderly: results of a retrospective study. Latagliata R; Sgadari C; Pisani F; Falconi M; Spadea A; Vegna ML; Petti MC Haematologica; 1989; 74(2):167-71. PubMed ID: 2501170 [TBL] [Abstract][Full Text] [Related]
3. Prognostic importance of cytogenetic subgroups in de novo pediatric acute nonlymphocytic leukemia. Kalwinsky DK; Raimondi SC; Schell MJ; Mirro J; Santana VM; Behm F; Dahl GV; Williams D J Clin Oncol; 1990 Jan; 8(1):75-83. PubMed ID: 2295913 [TBL] [Abstract][Full Text] [Related]
4. A single-center, retrospective study of management and outcome of 45 elderly AML patients, diagnosed in 2001. Alymara V; Tzouvara E; Vartholomatos G; Chaidos A; Tsiara S; Bourantas KL J Exp Clin Cancer Res; 2004 Sep; 23(3):447-54. PubMed ID: 15595635 [TBL] [Abstract][Full Text] [Related]
5. Childhood acute nonlymphocytic leukemia in 88 patients. Hung IJ; Yang CP; Jiang TH J Formos Med Assoc; 1994 Jun; 93(6):469-74. PubMed ID: 7858434 [TBL] [Abstract][Full Text] [Related]
6. Intensive chemotherapy and reduced-intensity allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia in elderly patients. Jackson K; Kennedy G; Mollee P; Marlton P; Morris K Asia Pac J Clin Oncol; 2014 Sep; 10(3):246-54. PubMed ID: 24673966 [TBL] [Abstract][Full Text] [Related]
8. [Improved results of treatment in 30 cases of acute nonlymphocytic leukemia in childhood]. Imashuku S; Arakawa S; Todo S; Esumi N; Tsunamoto K; Hashida T; Morioka Y; Hibi S; Nagai T; Fujiwara F Gan To Kagaku Ryoho; 1986 Aug; 13(8):2581-7. PubMed ID: 3740859 [TBL] [Abstract][Full Text] [Related]
9. The response to induction therapy is crucial for the treatment outcomes of elderly patients with acute myeloid leukemia: single-institution experience. Tasaki T; Yamauchi T; Matsuda Y; Takai M; Ookura M; Lee S; Tai K; Ikegaya S; Kishi S; Yoshida A; Urasaki Y; Iwasaki H; Ueda T Anticancer Res; 2014 Oct; 34(10):5631-6. PubMed ID: 25275066 [TBL] [Abstract][Full Text] [Related]
10. Randomized multicenter trial of cytosine arabinoside with mitoxantrone or daunorubicin in previously untreated adult patients with acute nonlymphocytic leukemia (ANLL). Lederle Cooperative Group. Arlin Z; Case DC; Moore J; Wiernik P; Feldman E; Saletan S; Desai P; Sia L; Cartwright K Leukemia; 1990 Mar; 4(3):177-83. PubMed ID: 2179638 [TBL] [Abstract][Full Text] [Related]
11. Analysis of prognostic factors for the outcome of marrow transplantation or further chemotherapy for patients with acute nonlymphocytic leukemia in first remission. Tallman MS; Kopecky KJ; Amos D; Dahlberg S; Hewlett JS; Files JC; Coltman CA; Thomas ED; Appelbaum FR J Clin Oncol; 1989 Mar; 7(3):326-37. PubMed ID: 2645386 [TBL] [Abstract][Full Text] [Related]
12. [Results of treating acute myeloblastic leukemia in patients over 60 years of age]. Robak T; Krykowski E; Brodowski L; Zawadzka-Bandura A; Urbańska-Ryś H; Błasińska-Morawiec M; Matusewicz W Pol Tyg Lek; 1991 Dec 2-9; 46(48-49):931-4. PubMed ID: 1845711 [TBL] [Abstract][Full Text] [Related]
14. Comparative trial of cytarabine and thioguanine in combination with amsacrine or daunorubicin in patients with untreated acute nonlymphocytic leukemia: results of the L-16M protocol. Berman E; Arlin ZA; Gaynor J; Miller W; Gee T; Kempin SJ; Mertelsmann R; Andreeff M; Reich L; Nahmias N Leukemia; 1989 Feb; 3(2):115-21. PubMed ID: 2911205 [TBL] [Abstract][Full Text] [Related]
15. Intensive chemotherapy for poor prognosis myelodysplasia (MDS) and secondary acute myeloid leukemia (sAML) following MDS of more than 6 months duration. A pilot study by the Leukemia Cooperative Group of the European Organisation for Research and Treatment in Cancer (EORTC-LCG). de Witte T; Suciu S; Peetermans M; Fenaux P; Strijckmans P; Hayat M; Jaksic B; Selleslag D; Zittoun R; Dardenne M Leukemia; 1995 Nov; 9(11):1805-11. PubMed ID: 7475266 [TBL] [Abstract][Full Text] [Related]
16. Low-dose cytarabine versus intensive chemotherapy in the treatment of acute nonlymphocytic leukemia in the elderly. Tilly H; Castaigne S; Bordessoule D; Casassus P; Le Prisé PY; Tertian G; Desablens B; Henry-Amar M; Degos L J Clin Oncol; 1990 Feb; 8(2):272-9. PubMed ID: 2299370 [TBL] [Abstract][Full Text] [Related]
17. Intensive chemotherapy, azacitidine, or supportive care in older acute myeloid leukemia patients: an analysis from a regional healthcare network. Bories P; Bertoli S; Bérard E; Laurent J; Duchayne E; Sarry A; Delabesse E; Beyne-Rauzy O; Huguet F; Récher C Am J Hematol; 2014 Dec; 89(12):E244-52. PubMed ID: 25195872 [TBL] [Abstract][Full Text] [Related]
18. Hyperleukocytosis in adult acute nonlymphocytic leukemia: impact on remission rate and duration, and survival. Dutcher JP; Schiffer CA; Wiernik PH J Clin Oncol; 1987 Sep; 5(9):1364-72. PubMed ID: 3625254 [TBL] [Abstract][Full Text] [Related]